Testing effectiveness (Phase 2)Study completedNCT02347176
What this trial is testing
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
Who this might be right for
Atopic Dermatitis
MedImmune LLC 204
Showing 20 of 0 results